1. Home
  2. GRI vs CNEY Comparison

GRI vs CNEY Comparison

Compare GRI & CNEY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GRI Bio Inc.

GRI

GRI Bio Inc.

HOLD

Current Price

$2.31

Market Cap

3.3M

Sector

Health Care

ML Signal

HOLD

Logo CN Energy Group Inc.

CNEY

CN Energy Group Inc.

HOLD

Current Price

$0.72

Market Cap

3.4M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRI
CNEY
Founded
2018
2009
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
3.3M
3.4M
IPO Year
2020
2019

Fundamental Metrics

Financial Performance
Metric
GRI
CNEY
Price
$2.31
$0.72
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$160.00
N/A
AVG Volume (30 Days)
73.1K
455.9K
Earning Date
05-14-2026
02-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.18
$0.12
52 Week High
$6.70
$3.25

Technical Indicators

Market Signals
Indicator
GRI
CNEY
Relative Strength Index (RSI) 46.40 51.99
Support Level $2.15 $0.54
Resistance Level $2.72 $1.14
Average True Range (ATR) 0.19 0.13
MACD -0.01 0.03
Stochastic Oscillator 37.12 42.86

Price Performance

Historical Comparison
GRI
CNEY

About GRI GRI Bio Inc.

GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis. It is also an oral formulation of tazarotene, a synthetic RAR-beta and gamma selective agonist for the topical treatment of psoriasis and acne. The company's other product candidate GRI-0803 is a novel oral agonist of type 2 Natural Killer T (type 2 NKT) cells which can be a potential treatment for autoimmune disorders.

About CNEY CN Energy Group Inc.

CN Energy Group Inc along with its subsidiaries is a manufacturer and supplier of wood-based activated carbon that is used in pharmaceutical manufacturing, industrial manufacturing, water purification, environmental protection, and food and beverage production and a producer of biomass electricity generated in the process of producing activated carbon. The firm generates a majority of its revenue from Activated carbon.

Share on Social Networks: